Bingyang Shi

NHMRC Leadership Fellow (EL2), Ph.D, Associate Professor

Calculated based on number of publications stored in Pure and citations from Scopus
20092023

Research activity per year

Personal profile

Biography

With the award of a competitive Macquarie University Research Fellowship in 2014, I relocated to Macquarie Uni (MQ) to lead a new Brain Drug Delivery Group. There I chase my research dream and ambition to address one of the major challenges for brain disease therapy which is the successful delivery of therapeutic agents across the Blood Brain Barrier (BBB) – the BBB acts as a cellular barrier that prevents toxins, foreign materials and other dangerous molecules from entering the brain, however as a consequence this poses major challenges for getting therapeutic molecules into the brain.

To overcome this, my research program is developing advanced brain drug delivery system to efficiently transport the therapeutic drug across BBB into Brain for preclinical brain disease therapy evaluation with three core research streams: 1) development of novel nanoparticle-based blood–brain barrier (BBB) penetration mechanisms; 2) development of brain delivery systems based on the BBB mechanisms discovered in stream 1; 3) preclinical evaluation of therapies for brain diseases based on the delivery systems developed in stream 2. Each research stream is led by an outstanding ECR team member managing 1-2 PhD students, but I maintain overall stewardship through weekly meetings with my ECR team and students to ensure progress remains on track.

I contributed my expertise & knowledge to develop a new Blood-Brain-Barrier (BBB) penetration mechanism, as well as pioneering new strategies for brain drug delivery that led to an NHMRC Peter Doherty Fellowship (GNT1111822) and NHMRC-ARC Dementia Research Development Fellowship (GNT1111611) (Declined the former and took the Dementia one). In 2016, I discovered a novel glucose-transporter-mediated BBB penetration pathway and drug-controlled-release strategy in neurons, developing an effective brain delivery strategy (Glu-NPs; 2017) and attracting a Mason Foundation grant (GNT MAS2017F034) and  NHMRC Project Grant (GNT1166024) for dementia therapy (both CIA; 2018). I lead a multidisciplinary team across MQ (myself, brain delivery; Dr Wright, Alzheimer’s disease (AD) biochemistry) and Western Sydney U (Dr. Chesworth, AD mouse behaviour) for these funded projects.

Inspired by the unique capabilities of natural cells, I developed another novel biomimetic brain delivery strategy (Bio-NPs) with outstanding therapeutic effects for brain tumour therapy, which led to an Australian Government Endeavour Research Fellowship (Recipient ID:6917_2018) to support a visit to Harvard University for six months to explore the potential applications in brain metastatic brain cancer therapy. Since 2019, I have been leading a 2nd multidisciplinary team across MQ, Henan province hospital, Huashan Hospital and Harvard Medical School for this project.

In recognizing my significant contributions to my research program, I was awarded five competitive fellowships (Macquarie University Research Fellowship, NHMRC Peter Doherty Fellowship, Australian Government Endeavour Research Fellowship, NHMRC-ARC Dementia Research Development Fellowship and NHMRC Leadership Fellow (EL2)), many prestigious awards, e.g, American Chem Society Rising star Award, MQ Early Career Researcher of the year in 2019, Rising star awards in Nanobiotechnology in 2022 (Journal of Nanobiotechnology, Springer Nature).

I am enthusiastic about training ECRs who have real interests and passion on exploring good science and technology for a better life to be future leaders in academia or industry. So far, I have supported & trained many ECRs to be successful in developing a competitive track record in their early career stage, including current members of my group (Dr Anne Zou, Macquarie Uni Research Fellowship 2018-2021 and NHMRC Emerging Leadership Fellowship 2022-2026; Dr Jia Li, Macquarie Uni Research Fellowship 2022-2024; Dr Guoying Wang, NSW Cancer Institute Fellowship 2023-2025). 

In the last three years (2020-2022), my group has received more than $4M CIA competitive grants to support our research program. We have PhD and postdoc positions opening for talented and passional candidates, feel free to contact me if interested. 

External positions

Executive Editor-in-Chief, Exploration, Wiley

1 Jan 2021 → …

honorary professor, Henan University

1 Jan 2016 → …

Fingerprint

Dive into the research topics where Bingyang Shi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or